4:00 PM SIGN-IN • 4:30 PM - 6:00 PM
BANDOL 2 (NEW WYNN SPACE)
CE: Multiple Sclerosis Update: Clinical, Economic, and Patient-Centric Strategies for Specialty Pharmacy Professionals
More than a dozen disease-modifying therapies (DMTs) are available for the treatment of MS with several additional novel therapies in late stage development. Early diagnosis and aggressive treatment is essential to minimize the MS disease burden and limit use of limited health care resources. Therefore, a high level of disease and therapeutic knowledge is necessary to effectively and efficiently manage the disease. The continually evolving MS treatment landscape accentuates the need for increased disease and therapeutic knowledge amongst managed care and specialty pharmacy professionals in order to optimize clinical outcomes, reduce treatment variability, and increase patient engagement in their own care. This program highlights opportunities for managed care and specialty pharmacy professionals to enhance the management of patients with MS by implementing and/or recommending evidence-driven practices and administrative routines based on current clinical trial data.
Mitzi Joi Williams